|
|
| Research article summary (published 18 Oct 2009): |
Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival.
Full Abstract
The three leucine-rich repeats and immunoglobulin-like domains (LRIG) genes encode integral membrane proteins. Of these, LRIG1 negatively regulates growth factor signaling and is implicated as a tumor suppressor in certain malignancies. In astrocytic tumors, the subcellular distribution of LRIG proteins is associated with specific clinicopathological features and patient survival. The role of LRIG proteins in oligodendroglioma has not previously been studied. Here we used immunohistochemistry to analyze the expression of the LRIG proteins in 63 oligodendroglial tumors, and evaluated possible associations between LRIG protein expression and clinicopathological parameters. Notably, cytoplasmic LRIG2 expression was found to be an independent prognostic factor associated with poor oligodendroglioma patient survival. This is the first report of an LRIG protein showing a negative effect on survival, suggesting that LRIG2 might have a function different from that of LRIG1, and possibly contributing to the etiology of oligodendroglioma.
Author information
Author/s: Holmlund, Camilla (C); Haapasalo, Hannu (H); Yi, Wei (W); Raheem, Olayinka (O); Brännström, Thomas (T); Bragge, Helena (H); Henriksson, Roger (R); Hedman, Håkan (H);
Affiliation: Departments of Radiation Sciences, Oncology, Umeå University, Sweden.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: Neuropathology : official journal of the Japanese Society of Neuropathology (Neuropathology), published in Australia. (Language: eng)
Reference: 2009-Jun; vol 29 (issue 3) : pp 242-7
Dates: Created 2009/08/03; Completed 2009/10/19;
PMID: 18992012, status: MEDLINE (last retrieval date: 10/19/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Semi-quantification of methionine uptake and flair signal for the evaluation of chemotherapy in low-grade oligodendroglioma.
30 Dec 2004 - Histological characteristics and biological behavior of oligodendrogliomas.
30 Dec 1979 - [Clinical and pathologic correlations between "pure" and "transitional" oligodendrogliomas]
30 Dec 1987 - Toward improved grading of malignancy in oligodendrogliomas using metabolomics.
29 Apr 2008 - [Oligodendroglioma. Clinical course in relation to histological grading]
27 Feb 1978 - Imaging molecular signatures in oligodendroglioma.
30 Oct 2004 - [Advances in diagnosis and treatment of oligodendrogliomas of the brain. Eighty-four surgical patients (author's transl)]
6 Apr 1982 - [Comparison of two methods of postoperative radiotherapy in anaplastic cerebral oligodendroglioma]
29 Apr 1993 - Oligodendrogliomas: a clinical, histological, immunocytochemical and lectin-binding study.
29 Sep 1991 - Brain scanning in oligodendrogliomas: a detailed neuropathology-scan correlation of 34 histologically verified cases.
30 Jul 1975
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.